Evaluation of Recombinant Human Interleukin-12 in Patients with Recurrent or Refractory Ovarian Cancer: A Gynecologic Oncology Group Study

This publication has 13 references indexed in Scilit:

• Inhibition of Angiogenesis In Vivo by Interleukin 12
  JNCI Journal of the National Cancer Institute, 1995
• Interleukin-12-Mediated Tumoricidal Activity of Patient Lymphocytes in an Autologous in Vitro Ovarian Cancer Assay System
  Gynecologic Oncology, 1995
• Levels of soluble interleukin-2 receptor-α are elevated in serum and ascitic fluid from epithelial ovarian cancer patients
  American Journal of Obstetrics and Gynecology, 1994
• Interleukin-12: A Recently Discovered Cytokine with Potential for Enhancing Cell-Mediated Immune Responses to Tumors
  Cancer Investigation, 1993
• Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers
  Cytokine, 1992
• Molecular characterization of interleukin 12
  Archives of Biochemistry and Biophysics, 1992
• Role of Cytokines in the Differentiation of CD4⁺ T‐Cell Subsets in vivo
  Immunological Reviews, 1991
• Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor.
  Proceedings of the National Academy of Sciences, 1991
• Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.
  Proceedings of the National Academy of Sciences, 1990
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
  The Journal of Experimental Medicine, 1989